Extractable nuclear antigen
Extractable nuclear antigens (ENAs) are over 100 different soluble cytoplasmic and nuclear
Clinical applications
An extractable nuclear antigen panel, or an ENA panel, tests for presence of autoantibodies in the blood that react with proteins in the cell nucleus. It is usually done as a follow-up to a positive antinuclear antibody (
Techniques
Gel-based
Since the discovery of ENAs, they have been used as a diagnostic tool in connective tissue disease. Two widely used gel-based techniques were used to identify anti-ENAs and their associations to disease in early work, double immunodiffusion (DID)
Hemagglutination, ELISA, Western Blot
Three additional techniques, passive hemagglutination, enzyme linked immunosorbent assay (ELISA), and western blotting (WB), can be used in order to identify ENAs and link them to specific diseases. Passive
Many labs use a combination of both of these techniques to improve efficiency without sacrificing specificity. The current recommendation by European Consensus workshops is to screen for positive anti-ENAs with the ELISA technique. A more specific test such as CIEP will follow with samples that are identified as positive.[6]
The six main antigens used in immunological laboratories for detection are
Terminology
ENAs originally referred to proteins found in a saline extract of
ENA (extractable nuclear antigen) panel tests, test for autoantibodies to proteins in the cell nucleus. The term "extractable" is derived from the ability to remove the autoantibodies from the nuclei with saline and common proteins. The method of identifying these specimens is why they are also referred to as antibodies to saline-extracted antigens.[9]
ENA
Anti-ENA is a grouping of antibodies often used to screen for
- anti-Sm (for SLE)
- anti-RNP (for MCTD)
- anti-La/anti-SS-B (for Sjögren's)
- anti-Ro/anti-SS-A(for Sjögren's)
- anti-Scl70 (for Scleroderma)
- anti-Jo (for Dermatomyositis)
Sensitivity and specificity of these tests depends on the type of assay employed, and will therefore vary by lab. The following table illustrates the sensitivity and specificity of ENA antibodies at detecting SLE with the ELISA technique.
Antibody (tested using ELISA) | Sensitivity (%) for SLE | Specificity (%) for SLE |
---|---|---|
Anti-Ro (SS-A) | 61 | 80–93 |
Anti-La (SS-B) | 27–35 | 88–97 |
Anti-Sm | 34–45 | 88–100 |
Anti-RNP | 39–64 | 84–97 |
Reference for all values:[11] |
In addition, the use of ENA testing has also been used for the study of wheat related disorders such as
- SSA (Ro)
- SSB (La)
- RNP/Sm
- Jo-1
- Sm
- Scl-70
- Chromatin
- Centromere
- Histone
- RNA polymerase III
73% of celiac disease subjects tested positive for anti-histone and was the most prevalent, which is typically associated with drug-induced lupus erythematosus. This implicates a high probability of an autoimmune disorder in patients with wheat-related disorders.[12]
References
- ^ PMID 30364021.
- PMID 11777822.
- ^ "Abbexa - Antibodies, Proteins, ELISA kits".
- ISBN 978-94-011-1670-1.
- ^ PMID 11253128.
- PMID 9566804.
- PMID 9773966.
- ^ "Immunopathology".
- ^ a b "Extractable Nuclear Antigen Antibodies (ENA) panel". Lab Tests online. June 21, 2018. Retrieved April 10, 2019.
- ^ ENA test (QUANTA Lite) product sheet. inovadx.com. URL: http://www.inovadx.com/Products/di_pdfs/708555/628555rEnglish.pdf ENA[permanent dead link]. Accessed on: November 5, 2007.
- PMID 11253128.
- PMID 29977112.
External links
- Extractable+Nuclear+Antigens at the U.S. National Library of Medicine Medical Subject Headings (MeSH)